SLF2 was identified as a tumor suppressor of B‐cell lymphomagenesis and a crucial regulator of CHK1, and its deficiency was associated with defective DNA damage response and synthetic lethality to SUMOylation inhibition. The gene discussed is CHEK1; the disease is neoplasm.